medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (4)

Hyaluronidase in dermatology

Vázquez FH, Asz SD

Language: Spanish
References: 24
Page: 292-294
PDF size: 125.69 Kb.


ABSTRACT

Hyaluronidase is an enzyme that hydrolyzes hyaluronic acid, promoting the diffusion of injected fluids in the tissues, and facilitating their absorption. In dermatology it is used to correct defects or complications of injectable hyaluronic acid gels, it increases the action of local anesthesia, prevents the risk of necrosis in sclerotherapy and has fibrinolitic action. Low doses are effective but must be used cautiously.


REFERENCES

  1. Mantovani C, Bryant AE, Nicholson G. “Efficacy of varying concentrations of hyaluronidase in peribulbar anaesthesia”. Br J Anaesth 2001; 86(6): 876-878.

  2. Bruera E, Neumann CM, Pituskin E, et al. “A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration”. Ann Oncol 1999; 10(10): 1255-1258.

  3. Rzany B, Becker-Wegerich P, Bachmann F. et al. “Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and recommendation for use”. J Cosmet Dermatol 2009; 8(4): 317-323.

  4. Smith KC. “Reversible vs nonreversible fillers in facial aesthetics: concerns and considerations”. Dermatol Online J 2008; 14(8): 3.

  5. Laugier JP, Shuster S, Rosdy M, et al. “Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: evidence that hyaluronidase can permeate the stratum corneum”. Br J Dermatol 2000; 142(2): 226-233.

  6. Kim E, Yamashita M, Kimura M, et al. “Sperm penetration through cumulus mass and zona pellucid”. Int J Dev Biol 2008; 52(5-6): 677-682.

  7. Puhvel SM, Reisner RM. “The production of hyaluronidase (hyaluronate lyase) by Corynebacterium acnes”. J Invest Dermatol 1972; 58(2): 66-70.

  8. Lokeshwar VB, Selzer MG. “Hyalurondiase: both a tumor promoter and suppressor”. Semin Cancer Biol 2008; 18(4): 281-287.

  9. Dempsey GA, Barrett PJ, Kirby IJ. Hyaluronidase and peribulbar block. Br J Anaesth 1997; 78(6): 671-4.

  10. Soparkar CN, Patrinely JR, Skibell BC, et al. “Hyaluronidase and Restylane”. Arch Facial Plast Surg 2007; 9(4): 299-300.

  11. Brody HG. “Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement”. Dermatol Surg 2005; 31(8 Pt 1): 893-897.

  12. Vartanian AJ, Frankel AS, Rubin MG. “Injected hyaluronidase reduces restylane-mediated cutaneous augmentation”. Arch Facial Plast Surg 2005; 7(4): 231-237.

  13. Hirsch RJ, Brody HJ, Carruthers JD. “Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid”. J Cosmet Laser Ther 2007; 9(3): 182-185.

  14. Clark LE, Mellette JR Jr. “The use of hyaluronidase as an adjunct to surgical procedures”. J Dermatol Surg Oncol 1994; 20(12): 842-844.

  15. Nevarre D; Tzarnas Ch. “The Effects of Hyaluronidase on the Efficacy and on the Pain of Administration of 1% Lidocaine”. Plast Reconstr Surg 1998: 101(2): 365-369.

  16. Zimmet SE. “Hyaluronidase in the Prevention of Sclerotherapy-induced Extravasation Necrosis A Dose-Response Study”. Dermatol Surg 1996; 22(1): 73-76

  17. Ferraro GM, Arrastia MC, Ziella ME. “Tratamiento combinado de cicatrices de larga evolución: resultado estético y reparador en un adolescente”. Rev Argent Dermatol 2007; 88(4): 206-212

  18. Friedman K, Pollack SV, Manning T, et al. “Degradation of porcine dermal connective tissue by collagenase and hyaluronidase”. Br J Dermatol 1986; 115(4): 403-408.

  19. Kakar PK, Puri RK, Venkatachalam VP. “Oral submucous fibrosis -treatment with hyalase”. J Laryngol Otol 1985; 99(1): 57-59.

  20. De Vries CR, Miller AK, Packer MG. “Reduction of paraphimosis with hyaluronidase”. Urology 1996; 48(3): 464-465.

  21. Matarasso A, Pfeifer TM. “Mesotherapy and injection lipolysis”. Clin Plast Surg 2009; 36(2): 181-192.

  22. Borchard K, Puy R, Nixon R. “Hyaluronidase allergy: a rare cause of periorbital inflammation”. Australas J Dermatol 2010; 51(1): 49-51.

  23. Andre P, Fléchet ML. “Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection”. J Cosmet Dermatol 2008; 7(2): 136-138.

  24. Hirsch RJ, Lupo M, Cohen JL, et al. “Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase”. J Drugs Dermatol 2007; 6(3): 325-328




2020     |     www.medigraphic.com